NO20030727D0 - Oral hurtigsmeltende formulering av en cyklooksygenase-2- inhibitor - Google Patents

Oral hurtigsmeltende formulering av en cyklooksygenase-2- inhibitor

Info

Publication number: NO20030727D0
Authority: NO; Norway
Prior art keywords: oral fast; cyclooxygenase; granules; blending; inhibitor
Prior art date: 2000-08-18

Application number

NO20030727A

Other languages

English (en)

Other versions

NO20030727L (no

Inventor

Trang T Le

Tugrul T Kararli

Mark J Kontny

Srikonda V Sastry

Janaki Ram Nyshadham

Jr Arthur J Pagliero

Original Assignee

Yamanouchi Pharma Tech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-18

Filing date

2003-02-14

Publication date

2003-02-14

2003-02-14 Application filed by Yamanouchi Pharma Tech Inc filed Critical Yamanouchi Pharma Tech Inc

2003-02-14 Publication of NO20030727D0 publication Critical patent/NO20030727D0/no

2003-03-24 Publication of NO20030727L publication Critical patent/NO20030727L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Zoology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Reproductive Health (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20030727A 2000-08-18 2003-02-14 Oral hurtigsmeltende formulering av en cyklooksygenase-2- inhibitor NO20030727L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US22634700P	2000-08-18	2000-08-18
PCT/US2001/025803 WO2002015885A2 (en)	2000-08-18	2001-08-17	Oral fast-melt formulation of a cyclooxygenase-2 inhibitor

Publications (2)

Publication Number	Publication Date
NO20030727D0 true NO20030727D0 (no)	2003-02-14
NO20030727L NO20030727L (no)	2003-03-24

Family

ID=22848576

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030727A NO20030727L (no)	2000-08-18	2003-02-14	Oral hurtigsmeltende formulering av en cyklooksygenase-2- inhibitor

Country Status (20)

Country	Link
US (1)	US20020049233A1 (no)
EP (2)	EP1309316A2 (no)
JP (2)	JP2004506681A (no)
KR (1)	KR20030045035A (no)
CN (1)	CN1638739A (no)
AT (1)	ATE374599T1 (no)
AU (3)	AU2001286530B2 (no)
BR (1)	BR0113293A (no)
CA (2)	CA2420190A1 (no)
CZ (1)	CZ2003422A3 (no)
DE (1)	DE60130801T2 (no)
DK (1)	DK1355631T3 (no)
ES (1)	ES2292614T3 (no)
IL (1)	IL154386A0 (no)
MX (2)	MXPA03001408A (no)
NO (1)	NO20030727L (no)
NZ (2)	NZ524123A (no)
PL (1)	PL360704A1 (no)
PT (1)	PT1355631E (no)
WO (2)	WO2002015886A2 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002303577B2 (en) *	2001-05-04	2006-06-08	Merck & Co., Inc.	Method and compositions for treating migraines
CN1633281A (zh) *	2001-09-26	2005-06-29	法马西亚公司	口内崩解的伐地考昔组合物
NZ532184A (en) *	2001-10-10	2005-12-23	Pharmacia Corp	Intraorally disintegrating valdecoxib compositions in which the excipient - a saccharide - is present in intimate association in an amount between 50% and 90%
MXPA04004290A (es) *	2001-11-07	2004-08-11	Pharmacia Corp	Composiciones de valdecoxib que se disgregan intraoralmente preparadas mediante un procedimiento de granulacion en lecho fluido.
US7838029B1 (en)	2003-07-31	2010-11-23	Watson Laboratories, Inc.	Mirtazapine solid dosage forms
EP1809248A2 (en) *	2004-11-04	2007-07-25	Merck & Co., Inc.	Process for granulating particles
JP4945917B2 (ja) *	2005-01-19	2012-06-06	大正製薬株式会社	薬物含有コーティング用核粒子
MX2007014470A (es)	2005-05-17	2008-02-06	Amicus Therapeutics Inc	Metodo para el tratamiento de enfermedad de pompe usando derivados de 1-desoxinojirimicina.
US20070098804A1 (en) *	2005-08-29	2007-05-03	Judith Aronhime	Solid particulate tadalafil having a bimodal particle size distribution
US7811604B1 (en)	2005-11-14	2010-10-12	Barr Laboratories, Inc.	Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
AU2006328880A1 (en) *	2005-12-23	2007-06-28	Lek Pharmaceuticals D.D.	Bursting pellets
EP2222282A1 (en) *	2007-11-15	2010-09-01	Pfizer Products Inc.	Dosage forms comprising celecoxib providing both rapid and sustained pain relief
KR20200032244A (ko)	2012-03-07	2020-03-25	아미쿠스 세라퓨틱스, 인코포레이티드	폼페병의 치료를 위한 고농도 알파-글루코시다제 조성물
CN104027319A (zh) *	2014-06-25	2014-09-10	万特制药(海南)有限公司	一种塞来昔布分散片及其制备方法
CA2961762C (en)	2014-09-30	2024-03-05	Amicus Therapeutics, Inc.	Highly potent acid alpha-glucosidase with enhanced carbohydrates
MY198085A (en)	2015-12-30	2023-07-31	Amicus Therapeutics Inc	Augmented acid alpha-glucosidase for the treatment of pompe disease
KR102618519B1 (ko)	2016-03-30	2023-12-28	아미쿠스 세라퓨틱스, 인코포레이티드	재조합 산 알파-글루코시다제를 포함하는 제형
US10227577B2 (en)	2016-03-30	2019-03-12	Amicus Therapeutics, Inc.	Method for selection of high M6P recombinant proteins
HRP20230576T1 (hr)	2017-05-15	2023-09-01	Amicus Therapeutics, Inc.	Rekombinantna ljudska kisela alfa-glukozidaza
US10350171B2 (en)	2017-07-06	2019-07-16	Dexcel Ltd.	Celecoxib and amlodipine formulation and method of making the same
CN108576205B (zh) *	2018-03-22	2022-01-04	湖北省农业科学院农产品加工与核农技术研究所	一种草莓联合干燥的处理方法
MX2021005967A (es)	2018-11-21	2021-10-13	Tremeau Pharmaceuticals Inc	Formas purificadas de rofecoxib, métodos de fabricación y uso.
JP2020183359A (ja) *	2019-05-09	2020-11-12	日医工株式会社	セレコキシブ含有医薬組成物
US10945992B1 (en)	2019-11-13	2021-03-16	Tremeau Pharmaceuticals, Inc.	Dosage forms of rofecoxib and related methods
MX2023002660A (es) *	2020-09-17	2023-03-28	Catalent Uk Swindon Zydis Ltd	Uso de tensioactivo con formulaciones de dosificacion a base de gelatina de pescado de alto peso molecular para mejorar caracteristicas de flujo.
US11161833B1 (en)	2021-04-09	2021-11-02	Tremeau Pharmaceuticals, Inc.	Deuterated etoricoxib, methods of manufacture, and use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995020380A1 (en) *	1994-01-31	1995-08-03	Yamanouchi Pharmaceutical Co., Ltd.	Intraorally soluble compressed molding and process for producing the same
US5633272A (en) *	1995-02-13	1997-05-27	Talley; John J.	Substituted isoxazoles for the treatment of inflammation
PE10898A1 (es) *	1995-06-13	1998-03-20	American Home Prod	Formulaciones orales de etodolac s (+)-
EP0910368A1 (en) *	1996-05-17	1999-04-28	Merck & Co., Inc.	Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
EP0839526A3 (en) *	1996-10-31	1999-01-07	Takeda Chemical Industries, Ltd.	Solid pharmaceutical preparation with fast buccal disintegration or dissolution
IT1293764B1 (it) *	1997-07-23	1999-03-10	Chiesi Farma Spa	Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
US6465009B1 (en) *	1998-03-18	2002-10-15	Yamanouchi Pharmaceutical Co., Ltd.	Water soluble polymer-based rapidly dissolving tablets and production processes thereof
SA99191255B1 (ar) *	1998-11-30	2006-11-25	جي دي سيرل اند كو	مركبات سيليكوكسيب celecoxib
WO2001041761A2 (en) *	1999-12-08	2001-06-14	Pharmacia Corporation	Valdecoxib compositions
US6316029B1 (en) *	2000-05-18	2001-11-13	Flak Pharma International, Ltd.	Rapidly disintegrating solid oral dosage form
WO2002067894A2 (en) *	2001-02-27	2002-09-06	Ranbaxy Laboratories Limited	Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors

2001
- 2001-08-13 CN CN01814092.0A patent/CN1638739A/zh active Pending
- 2001-08-17 NZ NZ524123A patent/NZ524123A/en unknown
- 2001-08-17 PT PT01965984T patent/PT1355631E/pt unknown
- 2001-08-17 JP JP2002520808A patent/JP2004506681A/ja not_active Withdrawn
- 2001-08-17 MX MXPA03001408A patent/MXPA03001408A/es not_active Application Discontinuation
- 2001-08-17 KR KR10-2003-7002392A patent/KR20030045035A/ko not_active Ceased
- 2001-08-17 JP JP2002520807A patent/JP2004512274A/ja not_active Withdrawn
- 2001-08-17 MX MXPA03001346A patent/MXPA03001346A/es not_active Application Discontinuation
- 2001-08-17 DK DK01965984T patent/DK1355631T3/da active
- 2001-08-17 PL PL36070401A patent/PL360704A1/xx not_active Application Discontinuation
- 2001-08-17 IL IL15438601A patent/IL154386A0/xx unknown
- 2001-08-17 US US09/932,500 patent/US20020049233A1/en not_active Abandoned
- 2001-08-17 EP EP01965987A patent/EP1309316A2/en not_active Withdrawn
- 2001-08-17 NZ NZ524115A patent/NZ524115A/en unknown
- 2001-08-17 ES ES01965984T patent/ES2292614T3/es not_active Expired - Lifetime
- 2001-08-17 DE DE60130801T patent/DE60130801T2/de not_active Expired - Fee Related
- 2001-08-17 CA CA002420190A patent/CA2420190A1/en not_active Abandoned
- 2001-08-17 EP EP01965984A patent/EP1355631B1/en not_active Expired - Lifetime
- 2001-08-17 WO PCT/US2001/025834 patent/WO2002015886A2/en not_active Ceased
- 2001-08-17 CA CA002418730A patent/CA2418730A1/en not_active Abandoned
- 2001-08-17 CZ CZ2003422A patent/CZ2003422A3/cs unknown
- 2001-08-17 AU AU2001286530A patent/AU2001286530B2/en not_active Ceased
- 2001-08-17 BR BR0113293-8A patent/BR0113293A/pt not_active Application Discontinuation
- 2001-08-17 AU AU8653001A patent/AU8653001A/xx active Pending
- 2001-08-17 AT AT01965984T patent/ATE374599T1/de not_active IP Right Cessation
- 2001-08-17 AU AU2001286533A patent/AU2001286533A1/en not_active Abandoned
- 2001-08-17 WO PCT/US2001/025803 patent/WO2002015885A2/en not_active Ceased
2003
- 2003-02-14 NO NO20030727A patent/NO20030727L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE60130801T2 (de)	2008-06-26
KR20030045035A (ko)	2003-06-09
DK1355631T3 (da)	2008-02-04
WO2002015885A2 (en)	2002-02-28
BR0113293A (pt)	2003-06-10
PL360704A1 (en)	2004-09-20
NO20030727L (no)	2003-03-24
ATE374599T1 (de)	2007-10-15
EP1309316A2 (en)	2003-05-14
DE60130801D1 (de)	2007-11-15
WO2002015886A2 (en)	2002-02-28
AU2001286533A1 (en)	2002-03-04
WO2002015885A3 (en)	2003-08-28
JP2004512274A (ja)	2004-04-22
IL154386A0 (en)	2003-09-17
CN1638739A (zh)	2005-07-13
NZ524123A (en)	2005-02-25
AU2001286530B2 (en)	2007-01-25
CA2420190A1 (en)	2002-02-28
US20020049233A1 (en)	2002-04-25
NZ524115A (en)	2004-10-29
CA2418730A1 (en)	2002-02-28
AU8653001A (en)	2002-03-04
EP1355631A2 (en)	2003-10-29
MXPA03001346A (es)	2003-06-06
CZ2003422A3 (cs)	2003-06-18
JP2004506681A (ja)	2004-03-04
PT1355631E (pt)	2007-11-29
ES2292614T3 (es)	2008-03-16
MXPA03001408A (es)	2005-06-30
EP1355631B1 (en)	2007-10-03
WO2002015886A3 (en)	2002-07-25

Publication	Publication Date	Title
NO20030727L (no)	2003-03-24	Oral hurtigsmeltende formulering av en cyklooksygenase-2- inhibitor
TWI256305B (en)	2006-06-11	Oral fast-melt pharmaceutical composition of a cyclooxygenase-2 inhibitor and process for preparing the same
UA63993C2 (uk)	2004-02-16	Фармацевтична лікарська форма, що швидко тане в роті (варіанти) та спосіб формування гранул
HUP0400636A3 (en)	2004-09-28	Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
BR9808429A (pt)	2000-05-23	Composição farmacêutica e processo para a sua preparação.
IS6002A (is)	2001-07-13	Pýrazólkarboxýlsýruafleiður, framleiðsla þeirra, lyfjasamsetningar sem innihalda þær
HUP0301932A3 (en)	2007-09-28	Benzophenones as inhibitors of il-1 beta and tnf-alpha, pharmaceutical compositions containing them and use of them for producing pharmaceutical compositions
DE69942154D1 (de)	2010-04-29	Medikamenthaltige zusammensetzung in aerosolform
ATE432919T1 (de)	2009-06-15	Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen
IS2156B (is)	2006-11-15	Settar bensensúlfonamíðafleiður sem forlyf fyrir COX-2 tálma, aðferð til þess að búa þær til, lyfjasamsetningar sem innihalda þær og notkun þeirra við framleiðslu lyfja
MA26968A1 (fr)	2004-12-20	Compositions pharmaceutiques contenant du maleate d'amlodipine.
MY127350A (en)	2006-11-30	Flash-melt oral dose formulations
NO20025674D0 (no)	2002-11-26	5-klor-3-(4-metansulfonylfenyl)-6'-metyl-[2,3']bipyridinyl i ren, krystallinsk form og fremgangsmåte for syntese
MXPA04003346A (es)	2004-09-28	Formulacion de dosis oral de disolucion instantanea.
DK1122254T3 (da)	2005-08-29	4-sulfonamidpiperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
AU2002341555A1 (en)	2003-09-02	Levothyroxine pharmaceutical compositions, methods of making and methods of administration
DE60103276D1 (de)	2004-06-17	Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
NO20054417L (no)	2005-09-23	Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
AR034435A1 (es)	2004-02-25	Agentes terapeuticos.
HUP0204422A3 (en)	2003-08-28	Calcium dicarboxylate ethers, methods of making the compounds, and pharmaceutical compositions containing them
PL393598A1 (pl)	2011-04-26	Kryształy F bezwodnego aripiprazolu i sposób ich wytwarzania oraz kompozycja farmaceutyczna je zawierająca, farmaceutyczny stały preparat doustny i sposób jego wytwarzania oraz sposób wytwarzania granulek
WO2004087648A3 (en)	2005-03-24	Stabilized phenytoin containing composition
IL164994A0 (en)	2005-12-18	Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof

Legal Events

Date	Code	Title	Description
2009-03-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application